Fc-comprising scDb-based trivalent, bispecific T-cell engagers for selective killing of HER3-expressing cancer cells independent of cytokine release

por Aschmoneit, Nadine, Kühl, Lennart, Seifert, Oliver, Kontermann, Roland E
Publicado 2021

The eIg technology to generate Ig-like bispecific antibodies

por Kühl, Lennart, Aschmoneit, Nadine, Kontermann, Roland E., Seifert, Oliver
Publicado 2022

A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells

por Aschmoneit, Nadine, Steinlein, Sophia, Kühl, Lennart, Seifert, Oliver, Kontermann, Roland E.
Publicado 2021

eIg-based bispecific T-cell engagers targeting EGFR: Format matters

por Kühl, Lennart, Schäfer, Annelie K., Kraft, Sebastian, Aschmoneit, Nadine, Kontermann, Roland E., Seifert, Oliver
Publicado 2023

Fc-based Duokines: dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc)

por Aschmoneit, Nadine, Kocher, Katharina, Siegemund, Martin, Lutz, Martina S., Kühl, Lennart, Seifert, Oliver, Kontermann, Roland E.
Publicado 2022

A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3

por Rau, Alexander, Kocher, Katharina, Rommel, Mirjam, Kühl, Lennart, Albrecht, Maximilian, Gotthard, Hannes, Aschmoneit, Nadine, Noll, Bettina, Olayioye, Monilola A., Kontermann, Roland E., Seifert, Oliver
Publicado 2021